...
首页> 外文期刊>Seminars in dialysis >Psychological Distress and Depression in Patients with Chronic Kidney Disease
【24h】

Psychological Distress and Depression in Patients with Chronic Kidney Disease

机译:慢性肾脏病患者的心理困扰和抑郁

获取原文
获取原文并翻译 | 示例

摘要

Depressive disorders are 1.5-4 times more prevalent in medically ill patients than in the general population. Mood disorders can be regarded as the final common pathway developing from the interaction among multiple pathophysiological, psychological, and socioeconomic stressors that chronic illness imposes on the individual. Symptoms of clinical depression affect approximately 25% patients on hemodialysis and can be associated with low quality of life and increased mortality. The epidemiology of depressive disorders is less well studied in the renal transplant population. However, depression is a risk factor for poor outcomes, such as graft failure and death after renal transplantation. A high prevalence of severe psychological distress in patients with advanced CKD and its impact on CKD outcomes call for screening and intervention integrated in routine renal care. Preliminary data indicate that some of the selective serotonin reuptake inhibitor agents and time-limited, manualized, structured psychotherapies can be safe and effective for treating depression in this population.
机译:与普通人群相比,医学疾病患者的抑郁症患病率高1.5-4倍。情绪障碍可以看作是慢性疾病强加于个人的多种病理生理,心理和社会经济压力源之间相互作用的最终最终共同途径。临床抑郁症的症状会影响大约25%的血液透析患者,并可能与生活质量低下和死亡率增加有关。在肾移植人群中,抑郁症的流行病学研究较少。但是,抑郁是不良结局的危险因素,例如移植肾衰竭和肾移植后死亡。晚期CKD患者的严重心理困扰的高患病率及其对CKD结局的影响要求在常规肾脏护理中进行筛查和干预。初步数据表明,某些选择性5-羟色胺再摄取抑制剂和限时的,手动的,结构化的心理治疗可以安全有效地治疗该人群的抑郁症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号